insights_auto
Why is NEU down 4.75%?
Dive Deeperchevron_right
NEU:ASX
Neuren Pharmaceuticals Ltd
A$18.65
arrow_downward
-4.75%(-0.93) 1D
Oct 26, 4:14:34 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$19.40
High
A$19.40
Low
A$18.58
Mkt. cap
2.36B
Avg. vol.
329.60K
Volume
444.93K
Dividend
0.80%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
120.81
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$19.40
High
A$19.40
Low
A$18.58
Mkt. cap
2.36B
Avg. vol.
329.60K
Volume
444.93K
Dividend
0.80%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
120.81
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
www.marketscreener.com
·
35 minutes ago
Three Companies on Nasdaq Stockholm Trade Ex-Dividend Today
IBS Intelligence
·
43 minutes ago
Nasdaq appoints Andrew Murray to lead Financial Technology in Singapore
Bloomberg.com
·
15 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
MarketWatch
·
15 hours ago
More than a third of S&P 500 companies are about to report earnings as market confidence cracks
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com